Abstract
Purpose
Evidence of an association between n-3 polyunsaturated fatty acids (PUFAs) and metabolic syndrome (MS) is limited and inconsistent. We investigated the association between n-3 PUFAs in erythrocytes and the presence of MS in Chinese adults.
Methods
The levels of α-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) in erythrocytes were measured using gas chromatography in 3072 participants (900 men and 2172 women) aged 30–75 years from Guangzhou, China. Cardiometabolic factors were determined, and MS was defined using the updated Adult Treatment Panel III criteria. Other covariates were collected via interviewer-administered questionnaires.
Results
After adjusting for age and other confounders, higher levels of marine-derived n-3 PUFAs, including EPA, DPA, and DHA, were associated with a lower presence of metabolic syndrome in both men and women. The odds ratios (95 % confidence interval) for MS obtained by comparing extreme quartiles were 0.55 (0.35–0.88) (EPA), 0.54 (0.34–0.87) (DPA), 0.45 (0.27–0.73) (DHA), and 0.52 (0.32–0.84) (total n-3 PUFAs) in men (p trend <0.05 for all results); and 0.74 (0.56–0.99) (EPA), 0.73 (0.55–0.98) (DPA), 0.75 (0.56–1.02) (DHA), and 0.71 (0.53–0.96) (total n-3 PUFAs) in women, respectively. No significant association of ALA with MS was observed (p trend > 0.05).
Conclusion
Higher levels of total n-3 PUFAs, EPA, DPA, and DHA, but not of ALA, in erythrocyte membranes are associated with a lower presence of metabolic syndrome in Chinese adults.
Similar content being viewed by others
References
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716
Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070–1077
Xi B, He D, Hu Y, Zhou D (2013) Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China health and nutrition survey in 2009. Prev Med 57:867–871
Abete I, Goyenechea E, Zulet MA, Martinez JA (2011) Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 21(Suppl 2):B1–15
Poudyal H, Panchal SK, Diwan V, Brown L (2011) Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 50:372–387
Barre DE (2007) The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes–a mini-review. J Oleo Sci 56:319–325
Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH et al (2011) Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome–LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond) 35:800–809
Warensjo E, Sundstrom J, Lind L, Vessby B (2006) Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 84:442–448
Vanhala M, Saltevo J, Soininen P, Kautiainen H, Kangas AJ, Ala-Korpela M et al (2012) Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study. Am J Epidemiol 176:253–260
Huang T, Bhulaidok S, Cai Z, Xu T, Xu F, Wahlqvist ML et al (2010) Plasma phospholipids n-3 polyunsaturated fatty acid is associated with metabolic syndrome. Mol Nutr Food Res 54:1628–1635
Zhang G, Sun Q, Hu FB, Ye X, Yu Z, Zong G et al (2012) Erythrocyte n-3 fatty acids and metabolic syndrome in middle-aged and older Chinese. J Clin Endocrinol Metab 97:E973–E977
Noel SE, Newby PK, Ordovas JM, Tucker KL (2010) Adherence to an (n-3) fatty acid/fish intake pattern is inversely associated with metabolic syndrome among Puerto Rican adults in the Greater Boston area. J Nutr 140:1846–1854
Kabagambe EK, Tsai MY, Hopkins PN, Ordovas JM, Peacock JM, Borecki IB et al (2008) Erythrocyte fatty acid composition and the metabolic syndrome: a National heart, lung, and blood institute GOLDN study. Clin Chem 54:154–162
Lai YH, Petrone AB, Pankow JS, Arnett DK, North KE, Ellison RC et al (2013) Association of dietary omega-3 fatty acids with prevalence of metabolic syndrome: the National heart, lung, and blood institute family heart study. Clin Nutr 32:966–969
Mayneris-Perxachs J, Guerendiain M, Castellote AI, Estruch R, Covas MI, Fito M et al (2014) Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. Clin Nutr 33:90–97
Mori TA, Burke V, Puddey IB, Watts GF, O’Neal DN, Best JD et al (2000) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71:1085–1094
Poudyal H, Panchal SK, Ward LC, Brown L (2013) Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J Nutr Biochem 24:1041–1052
Wang P, Chen YM, He LP, Chen CG, Zhang B, Xue WQ et al (2012) Association of natural intake of dietary plant sterols with carotid intima-media thickness and blood lipids in Chinese adults: a cross-section study. PLoS One 7:e32736
Zhang CX, Ho SC (2009) Validity and reproducibility of a food frequency Questionnaire among Chinese women in Guangdong province. Asia Pac J Clin Nutr 18:240–250
Yang YX, Wang GY, Pan XC (eds) (2002) China food composition Table 2002. Peking University Medical Press, Beijing
Zhang B, Wang P, Chen CG, He QQ, Zhuo SY, Chen YM et al (2010) Validation of an FFQ to estimate the intake of fatty acids using erythrocyte membrane fatty acids and multiple 3d dietary records. Public Health Nutr 13:1546–1552
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 112:2735–2752
Mozaffarian D, Wu JH (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58:2047–2067
Baik I, Abbott RD, Curb JD, Shin C (2010) Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc 110:1018–1026
Zak A, Burda M, Vecka M, Zeman M, Tvrzicka E, Stankova B (2014) Fatty acid composition indicates two types of metabolic syndrome independent of clinical and laboratory parameters. Physiol Res 63(Suppl 3):S375–385
Lottenberg AM, Afonso Mda S, Lavrador MS, Machado RM, Nakandakare ER (2012) The role of dietary fatty acids in the pathology of metabolic syndrome. J Nutr Biochem 23:1027–1040
Carpentier YA, Portois L, Malaisse WJ (2006) n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr 83:1499S–1504S
Jump DB (2008) N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 19:242–247
Vanschoonbeek K, Wouters K, van der Meijden PE, van Gorp PJ, Feijge MA, Herfs M et al (2008) Anticoagulant effect of dietary fish oil in hyperlipidemia: a study of hepatic gene expression in APOE2 knock-in mice. Arterioscler Thromb Vasc Biol 28:2023–2029
Jump DB, Clarke SD (1999) Regulation of gene expression by dietary fat. Annu Rev Nutr 19:63–90
Park Y, Harris WS (2003) Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 44:455–463
Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M et al (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383–1386
Auwerx J, Leroy P, Schoonjans K (1992) Lipoprotein lipase: recent contributions from molecular biology. Crit Rev Clin Lab Sci 29:243–268
Hirano R, Igarashi O, Kondo K, Itakura H, Matsumoto A (2001) Regulation by long-chain fatty acids of the expression of cholesteryl ester transfer protein in HepG2 cells. Lipids 36:401–406
Vedtofte MS, Jakobsen MU, Lauritzen L, Heitmann BL (2012) The role of essential fatty acids in the control of coronary heart disease. Curr Opin Clin Nutr Metab Care 15:592–596
Baxheinrich A, Stratmann B, Lee-Barkey YH, Tschoepe D, Wahrburg U (2012) Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of alpha-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. Br J Nutr 108:682–691
Wu H, Pan A, Yu Z, Qi Q, Lu L, Zhang G et al (2010) Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. J Nutr 140:1937–1942
Truong H, DiBello JR, Ruiz-Narvaez E, Kraft P, Campos H, Baylin A (2009) Does genetic variation in the Delta6-desaturase promoter modify the association between alpha-linolenic acid and the prevalence of metabolic syndrome? Am J Clin Nutr 89:920–925
Acknowledgments
The present study was jointly supported by the National Natural Science Foundation of China (81472965, 30872102) and by the 5010 Program for Clinical Researches (No. 2007032) of the Sun Yat-sen University (Guangzhou, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
No conflict of interest was declared.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dai, Xw., Chen, Ym., Zeng, Ff. et al. Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women. Eur J Nutr 55, 981–989 (2016). https://doi.org/10.1007/s00394-015-0912-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-015-0912-3